NeuroDex News

Neurodex News

NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood
NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood
Peer-reviewed study in the Journal of Extracellular Biology extends the company’s plasma EV platform...
NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS
NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS
NeuroDex’s neuron-derived extracellular vesicle (NDE) technology measured neuron-specific TDP-43 in blood...
tdp-43 biomarker
TDP-43 Biomarkers: Why the Next Decade of Neurodegeneration Research Will Focus on TDP-43
Why the world’s leading neurodegeneration researchers are converging on a single protein and why fluid...
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
New study in the Journal of Clinical Endocrinology & Metabolism demonstrates that NeuroDex’s ExoSORT...
NeuroDex to Present Neuron-Derived Extracellular Vesicle Biomarker Data at ADPD 2026
NeuroDex to Present Neuron-Derived Extracellular Vesicle Biomarker Data at ADPD 2026
As we delve into the complexities of neurodegenerative diseases, it becomes increasingly clear that understanding...
NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD
NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD
NeuroDex Powers Landmark Release: Neuron-Derived Extracellular Vesicle RNA-Sequencing Dataset Now Available...
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
February 2026 | NeuroDex, Inc. NeuroDex is proud to announce the publication of a comprehensive peer-reviewed...
Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes
Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes
ALS Biomarker – Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative disease that...
Dr. Erez Eitan to Participate in the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Dr. Erez Eitan to Participate in the 2025 International Congress of Parkinson’s Disease and Movement Disorders
We are thrilled to announce that Dr. Erez Eitan, NeuroDex’s chief executive officer (CEO) and chief scientific...
Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2025
Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2025
We are thrilled to announce that Dr. Erez Eitan, NeuroDex’s chief executive officer (CEO) and chief...
1 2 3
Back to top Drag